Disease-associated marked hyperalphalipoproteinemia

Matsuzawa, 1984, Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity. A case report, Atherosclerosis, 53, 207, 10.1016/0021-9150(84)90196-5

Koizumi, 1985, Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia, Atherosclerosis, 58, 175, 10.1016/0021-9150(85)90064-4

Yamashita, 1988, Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity, Atherosclerosis, 70, 7, 10.1016/0021-9150(88)90094-9

Tall, 1993, Plasma cholesteryl ester transfer protein, J. Lipid Res., 34, 1255, 10.1016/S0022-2275(20)36957-1

Inazu, 1990, Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation, N. Engl. J. Med., 323, 1234, 10.1056/NEJM199011013231803

Fielding, 1996, Cholesteryl ester transfer protein: friend or foe?, J. Clin. Invest., 97, 2687, 10.1172/JCI118719

Hirano, 1995, Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase, Arterioscler. Thromb. Vasc. Biol., 15, 1849, 10.1161/01.ATV.15.11.1849

Hirano, 2000, Pros and cons of inhibiting cholesteryl ester transfer protein, Curr. Opin. Lipidol., 11, 589, 10.1097/00041433-200012000-00004

Barter, 2012, Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk, J. Lipid Res., 53, 1755, 10.1194/jlr.R024075

Hirano, 1997, Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity, Arterioscler. Thromb. Vasc. Biol., 17, 1053, 10.1161/01.ATV.17.6.1053

Maruyama, 2003, Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia, Atherosclerosis, 166, 177, 10.1016/S0021-9150(02)00327-1

Nagano, 2004, Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese, J. Atheroscler. Thromb., 11, 110, 10.5551/jat.11.110

Saito, 1999, Epitope mapping for the anti-rabbit cholesteryl ester transfer protein monoclonal antibody that selectively inhibits triglyceride transfer, J. Lipid Res., 40, 2013, 10.1016/S0022-2275(20)32425-1

Goto, 2001, Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography, Atherosclerosis, 159, 153, 10.1016/S0021-9150(01)00476-2

Okazaki, 2006, Component analysis of HPLC profiles of unique lipoprotein subclass cholesterols for detection of coronary artery disease, Clin. Chem., 52, 2049, 10.1373/clinchem.2006.070094

Ishigami, 1994, Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins, J. Biochem., 116, 257, 10.1093/oxfordjournals.jbchem.a124516

Sakai, 1995, Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency, Eur. J. Clin. Invest., 25, 332, 10.1111/j.1365-2362.1995.tb01710.x

Zhong, 1996, Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels, J. Clin. Invest., 97, 2917, 10.1172/JCI118751

Corsetti, 2006, Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation, Atherosclerosis, 187, 191, 10.1016/j.atherosclerosis.2005.09.012

Costacou, 2011, High-density lipoprotein cholesterol in diabetes: is higher always better?, J. Clin. Lipidol., 5, 387, 10.1016/j.jacl.2011.06.011

Plengpanich, 2011, CETP deificiency due to a novel mutation in the CETP gene promoter and its effect on cholesterol efflux and selective uptake into hepatocytes, Atherosclerosis, 216, 370, 10.1016/j.atherosclerosis.2011.01.051

Khoury, 2014, Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia, Atherosclerosis, 234, 193, 10.1016/j.atherosclerosis.2014.02.032